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ABSTRACT: Antimicrobial peptides (AMPs) are seen as a
promising replacement to conventional antibiotics for the
prevention of skin wound infections. However, due to the short
half-life of AMPs in biological environments, such as blood, their
use in clinical applications has been limited. The covalent
immobilization of AMPs onto suitable substrates is an effective
solution to create contact-killing surfaces with increased long-term
stab i l i ty . In th i s work , an ant imicrobia l pept ide ,
RRPRPRPRPWWWW-NH2 (RRP9W4N), was covalently at-
tached to amphiphilic and ordered mesoporous Pluronic F127
hydrogels made of cross-linked lyotropic liquid crystals through 1-
ethyl-3-(3-(dimethylamino)propyl) carbodiimide (EDC) and N-
hydroxysuccinimide (NHS) chemistry. The AMP-hydrogels showed high antibacterial activity against Staphylococcus epidermidis,
Staphylococcus aureus, Pseudomonas aeruginosa, methicillin-resistant S. aureus (MRSA), and multidrug-resistant Escherichia coli for up
to 24 h. Furthermore, the AMP-hydrogels did not present any toxicity to human fibroblasts. The AMPs retained their antimicrobial
activity up to 48 h in human blood serum, which is a significant increase in stability compared to when used in dissolved state. A
pilot in vivo rat model showed 10−100× less viable counts of S. aureus on AMP-hydrogels compared with control hydrogels during
the first 3 days of infection. Studies performed on human whole blood showed that blood coagulated more readily in the presence of
AMP-hydrogels as compared to hydrogels without AMPs, indicating potential hemostatic activity. Overall, the results suggest that
the combination of amphiphilic hydrogels with covalently bonded AMPs has potential to be used as antibacterial wound dressing
material to reduce infections and promote hemostatic activity as an alternative to antibiotics or other antimicrobial agents, whose use
should be restricted.
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■ INTRODUCTION
Human skin is an effective barrier protecting underlying tissues
from microbial penetration, but it is also the tissue most
exposed to damage and injury.1 Wounded skin is a vulnerable
environment for bacterial colonization and infection.2 An
infected wound slows down the wound healing process and
can result in patient morbidity and high healthcare costs. If an
infected wound is not managed properly, it can lead to
septicemia and sometimes even death.3
Currently, as one of the first steps in the treatment of an
infected wound, antibiotics are frequently prescribed to
patients despite their ineffectiveness.4 However, an effective
antibiotic treatment requires microbial identification and
careful selection of antibiotics. Microbial analysis is often
both a challenging and time-consuming procedure.5 In some
cases, bacteria present in the wound have the ability to form
and exist within a biofilm. Such biofilms have a complex
structure and are usually resistant to host immune responses
and antibiotic treatments.6,7 Moreover, systemic antibiotic
treatment often does not provide the right antibiotic
concentration to the infected site and has been shown
ineffective in chronic granulating wounds.3,8 Most importantly,
antibiotic resistance is an increasing concern in wound
infections, and the Center for Disease Control in the United
States is predicting more deaths from antimicrobial infections
than from all cancers combined by 2050. Wounds colonized
with multiresistant bacteria cause further morbidity to the
patient and certainly complicate wound management.9−11
There have been numerous attempts to decrease wound
infections without resorting to antibiotic use. For example, in
recent years, wound dressings with a slow release of silver (Ag)
compounds have been marketed and used clinically.2 However,
apart from the effective role of Ag in killing bacteria, silver ions
can be toxic to all microorganisms and cells.12 Most other
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topical antiseptics are also nonselective and may be cytotoxic if
used for a longer period of time, thus, significantly hindering
the healing process.13 Equally as problematic, recent research
has also demonstrated that bacteria can develop a resistance to
Ag nanoparticles, placing Ag as no better than antibiotics in
regard to antimicrobial resistance.14
Considering all of the above-mentioned limitations, the
management of open skin wound infections will continue to be
a challenge for clinicians. Therefore, when it comes to
infection, prevention is the first line of defense for every
open wound. Thus, preventive wound care should mean
managing a wound at an early stage where microbes in a
contaminated wound still have limited proliferation and have
not yet penetrated deeper into the tissue to evoke a host
reaction.15,16
In this work, a contact-killing material for the prevention of
skin wound infections using antimicrobial peptides (AMPs) is
introduced. AMPs are part of the innate immune system with a
broad spectrum of activity against microbes.17 AMPs work by
interacting with the bacterial membrane followed by rapidly
rupturing it causing breakdown of the bacterial cell; this
mechanism of action is less prone to result in bacterial
resistance, making AMPs a better alternative than antibiotics or
some nanoparticles (such as Ag).18−20
Apart from their antimicrobial effect, AMPs have been
shown to have therapeutic potential for the treatment of skin
and other epithelial injuries.21 Two examples include
talactoferrin, which has been shown to stimulate wound
healing, and pexiganan, which was developed for the topical
treatment of diabetic foot ulcers.22,23 Another beneficial factor
regarding AMPs in wound management is their target
selectivity. This means that unlike most topical antibacterial
agents, AMPs do not present any toxicity to host cells when
used locally and at the right dosage.24
Despite these promising properties of AMPs as a potential
alternative to traditional antibiotics and antiseptic agents, the
inherent instability of such peptides toward metabolic
degradation is an obstacle for bringing them to the clinic.25
For example, when exposed to physiological ions or serum
conditions, such peptides in their free state have a half-life of
only a few minutes to a few hours.26−28 One promising way of
addressing the poor stability of such peptides and create a
long-lasting antibacterial surface is through covalent immobi-
lization of such peptides to wound healing materials.29 Several
studies have shown that AMPs can retain their antimicrobial
activity upon covalent immobilization onto various materi-
als.30−32 Moreover, the cytotoxicity of such peptides, which is
associated with using high peptide concentrations in a free
state, could be avoided by this binding approach.33,34
In this work, we developed an antimicrobial hydrogel by
co v a l e n t immob i l i z a t i on o f a c a t i on i c AMP ,
RRPRPRPRPWWWW-NH2 (RRP9W4N), onto ordered
amphiphilic mesoporous hydrogels made of cross-linked
Pluronic F127 triblock copolymer and water. Such hydrogels
were made by cross-linking diacrylated F127 in its liquid
crystalline form to give a micellar cubic phase according to its
phase diagram.35,36 Covalent immobilization of AMPs to such
materials formed a soft 3D antibacterial hydrogel with high
liquid-absorption properties. It has previously been shown that
AMPs physically loaded into dispersed cubic lyotropic liquid
crystalline gel particles (cubosomes) exerted high bactericidal
activity and improved stability toward enzymatic degradation
without releasing the peptides.37 We investigated whether the
same effects can be observed when AMPs are covalently
attached to 3D and macroscopic cubic lyotropic liquid
crystalline hydrogels. Such hydrogels possess an amphiphilic
structure exposing its hydrophilic sites for the covalent
attachment of AMPs, while the hydrophobic parts of the
hydrogels provide for hydrophobic interactions with amphi-
philic AMPs to increase immobilization and stability of the
AMPs.
An ideal wound dressing should do more than just serve as a
protective barrier. For example, high absorptive properties and
capability to preserve humidity and create a moist environment
at the wound site would facilitate wound healing and increase
comfort.38−40 The wound dressing should be nontoxic, cause
no adverse side effects and be easily removable without causing
trauma or damage to the wound and surrounding tissue.
Finally, they should have antimicrobial properties to prevent
infection since infected wounds delay healing and cause patient
morbidity. Moreover, the ability to control bleeding in acute
wounds is an interesting additional property of a wound
dressing. In this study, we investigated whether such criteria
are present in AMP-functionalized hydrogels for their future
use as an effective antimicrobial wound dressing material. The
objective of this study is to evaluate whether covalent
immobilization of AMPs onto F127 hydrogels can act as
contact-killing surfaces against bacteria and have favorable
properties to be used as antimicrobial wound patches.
■ MATERIALS AND METHODS
All chemicals used in this synthesis were provided by Sigma-Aldrich
(Stockholm, Sweden) unless specified.
Manufacturing of Amphiphilic Hydrogels. Diacrylated Plur-
onic F127 (DA-EO100PO70EO100-DA) (30 wt %) and water (70%)
were mixed to form a homogeneous gel possessing a micellar cubic
lyotropic liquid crystalline phase according to a well-known phase
diagram of the relevant lyotropic liquid crystals.36 Irgacure 2959 was
added to the gel (2 wt % with respect to the MF127) as a
photoinitiator. Mixing was performed in 20 mL glass vials manually
using a spatula until a thick and homogeneous gel formed. The gels
were spread onto glass slides and kept in a sealed container overnight
to set into the micellar cubic phase. The gels were then UV
polymerized by a UV LED curing system (UVA, λ = 365 nm, 9 W)
for 10 min to form a flexible polymeric hydrogel with a thickness of
1−2 mm. The gels were cut into desired shapes and washed in milli-Q
water for 48 h to remove any unwanted byproducts and obtain their
fully swollen shape before further analysis and AMP attachment.
Synthesis of Polymerizable F127 (MF127). Pluronic F127 was
chemically functionalized with polymerizable diacrylate head groups
as previously reported.35,41 The modified polymer was used for the
manufacturing of cross-linked MF127 hydrogels for AMP modifica-
tion (Figure 1).
AMP Immobilization on Hydrogels. A solution of antimicrobial
peptide (AMP) RRPRPRPRPWWWW-NH2 (RRP9W4N, Red Glead
Discovery AB, Lund, Sweden) was prepared in sterilized water to a
Figure 1. Chemical reaction for the synthesis of the modified Pluronic F127(MF127). TEA stands for triethylamine.
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final concentration of 200 μM. The AMP consists of Arginine-Proline,
RP, sequences, which provide high positive net charges for increased
electrostatic interactions with bacteria. The hydrophobic part of the
peptide consists of Tryptophan, W, which has been shown to improve
the peptide interactions with phospholipid membranes and increase
bactericidal activity.26,42 Covalently attached RRP9W4N has
previously been shown to possess high antibacterial activity against
various bacterial strains and improved stability in physiological salt
and serum conditions.43
For the covalent attachment of AMP to the hydrogels, prior to
AMP modification, the clean hydrogels were submerged into a
solution of 1-ethyl-3-(3-(dimethylamino)propyl) carbodiimide hydro-
chloride (EDC) and N-hydroxysuccinimide (NHS) mixed in MES
buffer (pH 6) at a final concentration of 2 mg/mL and were allowed
to react for 30 min on a slow shaker at room temperature. Hydrogels
were then washed three times in PBS (pH 7.4), sterilized using 70%
ethanol, and suspended in 1 mL of a 200 μM AMP solution in
sterilized water for 2 h at RT. The surfaces were washed three times
with sterile water to remove unreacted peptides. We measured the
maximum number of covalently attached AMPs before the washing
steps to be 0.031 ± 0.013 mg/disc (4 mm in diameter and 0.7 mm in
thickness) using UV−visible spectroscopy at λ = 280 nm. For this
measurement, we used pure PBS as the blank and measured the AMP
concentration solution after the immobilization process using a
standard curve.
All AMP and control hydrogels were used in experiments within 7
days from production. A schematic of AMP covalent immobilization
via EDC-NHS activation is shown in Figure 2. This method utilizes
carboxyl groups present on the surface of the hydrogels for direct
coupling with primary amine groups present in the AMP. EDC was
used to activate carboxyl groups, and NHS was used to improve the
reaction efficacy and dry state stability of the reactive intermediates.
Bacterial Culture and Growth. Staphylococcus epidermidis
(ATCC 35984), Staphylococcus aureus (CCUG 56489), and
Pseudomonas aeruginosa (CCUG 10778) were used to assess colony
formation on the hydrogels. One day prior to the experiments, a fire-
sterilized metal loop was used to withdraw a single colony from
cultured brain heart infusion (BHI) agar plates of each strain to
inoculate a tube of 5 mL of tryptic soy broth (TSB), which was
cultured at 37 °C for 6 h under shaking at 250 rpm, further diluted in
TSB (1:1000), and cultured at 37 °C under shaking at 150 rpm
overnight to reach the stationary phase for bacterial growth.
The optical density (OD) of the bacterial culture was adjusted to
0.7 at 600 nm, estimated to give 109 colony-forming units (CFU/mL)
using a spectrophotometer. The bacterial suspension was centrifuged
for 10 min at 2500 rpm, and the bacterial cell pellet was suspended in
fresh TSB medium. Approximately 109 CFU in 1 mL of suspension
was seeded onto hydrogels (with and without AMP modification)
placed in 24-well plates. Bacteria were then cultured for 24 h under
static culture conditions at 37 °C to promote biofilm formation on the
surfaces. Finally, the hydrogels were rinsed three times with fresh PBS
to wash off the unattached planktonic bacteria before biofilm imaging
with fluorescent microscopy.
MRSA and MDR Escherichia coli Culture and Growth. A
single bacterial colony of MRSA (ATCC 43300) and MDR E. coli
(ATCC BAA-2471) was isolated from cultured BHI agar plates and
inoculated in 5 mL of TSB cultured in a shaking incubator at 37 °C
overnight. The optical density of the bacterial suspension was
adjusted to OD620 nm = 0.52 (equivalent to 10
9 CFU/mL) and further
diluted in TSB to obtain an inoculum of 106 CFU/mL. Material
samples were placed in a standard 24-well plate, and 1 mL of
inoculum was used to seed each sample followed by incubation for 24
h at 37 °C and 5% CO2.
Bacterial Live/Dead Fluorescence Analysis. To directly
analyze the population of live and dead cells of the different bacterial
species on the surface of the hydrogels, fluorescent microscopy with
live/dead staining was performed. The live/dead population of S.
epidermidis, S. aureus, and P. aeruginosa was assessed in a Zeiss Axio
Imager Z2m fluorescent microscope, whereas a Zeiss Axio Observer
was used for the analysis of MRSA and MDR E. coli on the hydrogel
surfaces.
After incubation, the bacterial suspension was removed from the
hydrogels and the samples were gently rinsed twice with PBS. A drop
of live/dead staining solution from LIVE/DEAD BacLight Bacterial
Viability Kit L7007, prepared according to the manufacturer’s
instructions, was placed on top of the sample to cover its surface.
The samples were incubated for 10 min at room temperature in a dark
environment before imaging. Prior to imaging, each sample was
divided into 20 equal parts to prespecify the imaging spots. Twenty
images from each surface were used to obtain the image analysis data
using ImageJ software. All live/dead-experiments were conducted
three times with three replicates.
Stability Assessment. Serum Stability. The duration of the
antimicrobial functionality of the AMP-hydrogels was evaluated upon
incubation in human serum. After AMP modification, the hydrogels
were placed in wells of a 24-well microtiter plate. To each well, 0.4
mL of 20% human serum (from human male plasma) (Sigma) diluted
in sterile milli-Q water was added and samples were incubated at
room temperature from 1 h to 2 days. At each time point the serum
was removed; the hydrogels were washed in PBS, and bacterial
culturing using 108 CFU/mL of S. aureus (CCUG 56489) suspension
in TSB for 24 h was performed to investigate how long the attached
AMPs retained their bactericidal activity. The experiment was carried
out with sample duplicates, and two independent experiments were
performed (n = 2).
Zone of Inhibition. In order to confirm that the AMPs were
covalently attached to the hydrogels, preventing them from leaking
out, zone of inhibition tests were performed. The S. aureus (CCUG
56489) culture was made in TSB at an optical density between 0.55
and 0.7. The bacteria pellet was collected by centrifugation (2500
rpm, 10 min) and suspended in 20 mL of fresh TSB, yielding 109
CFU/mL. BHI agar plates were then streaked evenly with 100 μL of
the bacterial suspension to reach confluent growth and cover the
entire agar surface. The hydrogels (two with and two without AMP)
were placed on top of the agar plates. As a control, hydrogels were
submerged in the same solution of AMP (200 μM) without the EDC
coupling agent, rinsed in PBS, and used to show the leakage difference
between AMP covalent and physical attachment. The plates were
incubated at 37 °C overnight. Afterward, the inhibition zones around
the hydrogels where no bacteria had grown were measured from a
Figure 2. Schematic of EDC-NHS activation and AMP attachment on
hydrogels.
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digital photograph and compared between the samples. The
inhibition zone area outside of the hydrogel contours was considered
a consequence of leaked AMP from the hydrogels into the
surrounding agar.
PBS Washing. To assess the stability of covalently bonded AMPs
onto hydrogel surfaces, a 14 day washing experiment with PBS was
performed. In this test, hydrogel with covalently bonded AMPs and
physically absorbed AMPs (submerged in 200 μM AMP solution
without the EDC/NHS coupling) as controls were placed in wells of a
24-well microtiter plate. To each well, 1 mL of PBS (pH = 7) was
added, and samples were incubated at room temperature for up to 14
days. Samples were taken out at the end of each time point (each day,
0−14 days) and bacterial tests using 108 CFU/mL of S. epidermidis
(ATCC 35984) suspension in TSB for 24 h was performed to
investigate how long each surface could retain their antibacterial
activity. The experiment was carried out with sample triplicates, and
two independent experiments were performed (n = 2).
Blood Coagulation Test (Platelet Count). Blood collecting
Eppendorf tubes, pipet tips, and tubings to draw blood were
heparinized to avoid unwanted blood activation. Heparinization was
performed according to the Corline method (Corline Biomedical AB,
Uppsala, Sweden): a layer-by-layer assembly method with alternating
incubation with a polymeric amine and a heparin conjugate to obtain
a double-coated heparin layer.
Fresh blood from two healthy human volunteers was collected in
heparinized tubes containing 1 IU/mL of a heparin solution (Leo
Pharma A/S, Ballerup, Denmark). The blood was used fresh after
sampling. In an Eppendorf tube, 1 mL of blood with 4 mM EDTA
was collected for use as a reference point (referred herein as initial).
Samples were conditioned by adding 1 mL of PBS and vortexed at
600 rpm for 30 min prior to the experiment. The hydrogels (control
and AMP modified) were placed in heparinized 2.5 mL Eppendorf
test tubes. A volume of 100 μL of PBS was added to soak the samples,
and subsequently 1 mL of fresh blood was added to each tube. The
tubes were then rotated on an orbital shaker (Incubating Waver,
VWR) for 60 min at 37 °C. As blank controls, 1 mL of blood was
added to an Eppendorf tube without any hydrogels and treated with
the same conditions. After the experiments, the blood was carefully
collected from the tubes and mixed with EDTA, giving a final
concentration of 4 mM. The number of platelets was counted using a
Sysmex XP-300 hematology analyzer (Kobe Japan). Samples were run
in duplicate with blood from each donor (n = 2). Ethical approval was
obtained from the regional ethics committee Dnr: 2008/264.
MTT Assays. Primary fibroblasts (Gibco Human Dermal
Fibroblasts, adult (HDFa); Fisher Scientific) were thawed and
subcultured according to the supplier’s recommendation. Briefly,
cells were cultured and expanded in Dulbecco’s Modified Eagle
Medium (DMEM) cell media supplemented with 1 μg/mL
hydrocortisone, 10 ng/mL human epidermal growth factor, 3 ng/
mL basic fibroblast growth factor, 10 μg/mL heparin, 10 μg/mL
gentamicin, and 0.25 μg/mL amphotericin B and 10% FBS by volume
at 37 °C and 5% atmospheric CO2. To perform MTT assays, hydrogel
samples (thin hydrogel discs punched out with a 4 mm biopsy punch)
were soaked in 1 mL of supplemented DMEM for 3 days. A volume of
200 μL of the sample-exposed media was added to the wells of a 96-
well plate. As negative controls, media not exposed to any samples
were used. Four replicates of each kind were used, and the experiment
was run twice (n = 2). The fibroblast concentration was calculated
using a Bürker counting chamber. Five thousand fibroblasts were then
added to each well. The plate was incubated at 37 °C for 3 days. After
incubation, the media was aspirated from each well and replaced with
100 μL of fresh media (of corresponding type) to which 10 μL of the
MTT solution (5 g of MTT in 1 mL of PBS) was added and mixed
gently by pipetting. After 4 h additional incubation, 100 μL of an SDS
solution (1 g of SDS in 10 mL of 0.01 M HCl) was added to each well
and placed in the incubator for another 4 h. The absorbance of each
well was read at 570 nm by a spectrophotometer (Thermo Scientific
Multiskan GO). The blank control (media and MTT stain without
any cells) absorbance was subtracted from each value, and the viability
of the cells was calculated by dividing the absorbance values with the
mean of the negative controls. A cell viability value of 70% was
considered as a standard for nontoxic material sample.
Pilot In Vivo Infection Study Using a Rat Model. Animal
Handling. Seven female Sprague−Dawley rats (200−300 g) fed on a
standard pellet diet and water were used in the study, which was
approved by the Local Ethical Committee for Laboratory Animals
(Dnr 1091/17). The animals were housed together (2−3 rats/cage)
and kept at the infection unit at the animal facility with daily
supervision. Anesthesia was induced by isoflurane inhalation (4% with
air flow of 650 mL/min) and maintained with continuous
administration of isoflurane (∼2% with an air flow of 450 mL/min)
via a mask (Univentor 400 anesthesia unit, Univentor, Zejtun, Malta).
The back of the rats was shaved and cleaned with chlorhexidine (5
mg/mL; Fresenius Kabi, Norway). On the back of the rats, six
separate incisions were made and pockets created by blunt dissection
in the soft tissue under the skin into which hydrogel disks were
inserted.
Surgical Procedure. On the back of each rat, three control
hydrogels and three AMP-hydrogels were inserted. A volume of 50 μL
of saline with or without S. aureus (ATCC 25923), at two different
dosages (104 and 2 × 106 CFU), was pipetted into the pocket before
careful closure of the wound with intracutaneous sutures followed by
2−3 simple sutures (Ethilon 5-0 FS-2, Eticon, Johnson & Johnson,
Scotland). The back was cleaned with saline, and each rat received
analgesics at a dose of 0.03 mg/kg (Temgesic, Reckitt Benckiser, UK).
Animals were sacrificed after 24 or 72 h with an overdose of
pentobarbital (60 g/L, APL, Sweden) after a short anesthetic
induction with isoflurane. The back of the rats was cleaned with
chlorhexidine, and all sutures were removed. The implants were
retrieved into a saline-containing tube, and the exudates were
obtained from the pockets by repeated aspiration (5×) with 500
mL of phosphate-buffered saline (PBS) and kept on ice until CFU
determination.
Statistical Analysis. The numerical data for the live/dead
bacterial cells were obtained by calculating the red and green
fractions from fluorescent microscopy images using ImageJ software
and are presented by their mean values and standard deviations. The
experiments were conducted three times (n = 3) with three sample
replicates. For the serum stability test, duplicate samples were used,
and two independent experiments were performed (n = 2). Twenty
images from each surface were used to obtain the image analysis data.
Paired Student’s t test was performed for data analysis. Data from
MTT assay are presented by mean values and standard deviation,
averaged over four replicates and two biological replicates (n = 2).
Data analysis was performed using Welch’s t test. Data from the blood
coagulation test are presented as mean values and standard deviation,
with four replicate samples using blood from two different donors (n
= 2). A p-value < 0.05 was considered significant.
■ RESULTS AND DISCUSSION
Manufacturing of Amphiphilic Hydrogels. In this
study, a hydrogel consisting of a cross-linked diacrylate-
modified triblock copolymer (F127) and water was used as a
substrate for AMPs functionalization. The material is an
antimicrobial hydrogel based on the covalent immobilization
of antimicrobial peptides (AMPs) onto F127 hydrogels. As a
preventive wound care patch, such materials here demon-
strated local killing of bacteria in contact with the patch
surface, showing potential to decrease the bioburden (i.e., the
amount of pathogen) in the wound and prevent bacteria
invasion deeper into the tissue.
The hydrogel possessed an ordered mesoporous structure
consisting of alternating hydrophilic and hydrophobic domains
previously characterized using small-angle X-ray scattering
(SAXS).44 The hydrogel retained its ordered structure after
cross-linking.35,41 This ordering repeats itself throughout the
gel, exposing both hydrophilic and hydrophobic domains on its
surface and making them available for the covalent attachment
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of peptides. On the basis of earlier observations that physically
immobilized (not covalently anchored) AMPs on hydrogel
cubosomes possessed high antimicrobial activity,37 it was
speculated that the amphiphilicity of the hydrogels will result
in favorable hydrophobic interactions with the AMPs, which
also are amphiphilic. This interaction was hypothesized to
result in the orientation, alignment, and specific AMP binding
(on the hydrophilic or hydrophobic parts of the hydrogel).
Moreover, the hydrogel has a high liquid absorption capacity
and owing to its amphiphilicity can maintain both polar and
nonpolar liquids in its structure. In Figure 3a, a 3D-printed
hydrogel mesh is shown before and after water absorption. A
schematic of the mesostructured phase of the hydrogel is
shown in Figure 3b.
Antimicrobial Peptide Modification and Bacterial
Response. The results of this study showed that the AMP-
hydrogel had high antimicrobial activity against S. epidermidis,
S. aureus, and P. aeruginosa. In Figure 4a, 4b, and 4c, images
from fluorescent microscopy with live/dead staining show a
very high bactericidal efficiency of the AMP-hydrogel
compared to the control hydrogel. Moreover, the total
colonized area by live bacteria on the surfaces of AMP-
hydrogels was significantly smaller than on the control
hydrogel. As seen in Figure 5a and 5b, a ∼90% reduction of
live S. epidermidis and S. aureus and in Figure 5c a ∼70%
reduction of live P. aeruginosa were observed on the AMP-
hydrogel surfaces compared with control hydrogels. In
addition, the proportion of dead cells increased by ∼70% for
S. epidermidis, ∼80% for S. aureus, and ∼50% for P. aeruginosa.
Similarly, the AMP-hydrogels were effective at decreasing
colonization by antimicrobial-resistant strains, such as MRSA
and MDR E. coli. Specifically, the images of live/dead bacteria
obtained from fluorescent microscopy (Figure 6a and 6b)
show a greater population of dead cells on the AMP-hydrogels
compared to control hydrogels. According to Figure 7a, the
results showed a ∼65% reduction in the fraction of live and a
Figure 3. (a) Three-dimensional-printed hydrogel mesh before (left)
and after (right) swelling in water. (b) Schematic of the micellar cubic
lyotropic LLC phase which is the mesostructured phase of the
hydrogel used in this work. (l1) indicates micellar cubic phase.
Figure 4. Images of bacteria attached onto hydrogels with and
without AMP. Bacteria were stained by SYTO 9 and propidium
iodide. Live bacteria appear as green, and dead bacteria appear as red.
(a) S. epidermidis, (b) S. aureus, and (c) P. aeruginosa..
Figure 5. Quantitative analysis of the live and dead fractions of (a) S.
aureus, (b) S. epidermidis, and (c) P. aeruginosa colonization on
hydrogel surfaces with and without AMP attachment. Values were
obtained from analyzing fluorescent images using ImageJ software.
Values are mean ± SD, triplicate samples were used, and three
independent experiments were performed (n = 3), *p < 0.05
compared to control groups (hydrogels with no AMP).
Figure 6. Fluorescence images of bacterial cells attached onto
hydrogels with and without AMP. Bacteria were stained by SYTO 9
and propidium iodide. Live bacteria appear as green, and dead
bacteria appear as red. (a) Methicillin-resistant S. aureus and (b)
multidrug-resistant E. coli.
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∼50% increase in the fraction of dead MRSA on the AMP-
hydrogels. While, as shown in Figure 7b, the fraction of dead
MDR-E. coli had a ∼90% reduction on AMP-hydrogels, there
was no considerable decrease in the fraction of live cells.
Overall, the results from the live/dead fluorescence in vitro
study suggest that covalent attachment of AMPs onto the
amphiphilic hydrogel formed a very effective contact-killing
effect toward a broad spectrum of bacterial species (including
multiresistant strains). If such materials are to be used as
antibacterial wound patches, they can potentially kill a range of
Gram-positive and Gram-negative bacteria present at the
wound surface and may hinder their penetration into deeper
tissues.
Stability Assessment. Serum Stability. In the present
study, the stability of peptides was examined in human blood
serum. The stability of peptides in serum or plasma is
considered as a representative model for their in vivo
stability.45 As seen in Figure 8, the covalently attached
peptides kept their antibacterial effect against S. aureus for
up to 2 days, showing a significantly higher proportion of dead
cells on AMP samples compared to control samples for each
time point when incubated in human serum, while the serum
stability of the same analogues of the peptide in diluted serum
showed a half-life between 0.5 and 6.5 h in previous studies.26
The results in the present study suggest that covalent
attachment of peptides can considerably increase peptide
stability compared to when the peptides are released. Previous
work has shown that the AMP under investigation also
possessed an increased stability after 24 h when covalently
bonded to an elastin-like polypeptide matrix.43
Suggested explanations for why AMPs lose their activity in
serum are either the increased ionic strength or the presence of
other proteins and enzymes in the serum. Peptides rich in
cationic components are more susceptible to degradation since
the charged components in their structure, such as arginine
and lysine, expose more cleavage sites to enzymes present in
blood.26
Zone of Inhibition. In order to ensure that the AMPs are
covalently attached to the hydrogels and do not leak out, a
zone inhibition test was performed. Hydrogels with covalently
attached AMPs were compared to hydrogels with physically
adsorbed AMPs. Hydrogels were placed on top of a BHI agar
plate previously streaked with S. aureus and incubated at 37 °C
overnight. Images of the zone inhibition tests are presented in
Figure 9. A clearly visible inhibition zone (radius of ∼7 mm)
around the hydrogels with physically adsorbed AMPs could be
measured, whereas no inhibition zones were present around
the hydrogels with covalently bonded AMPs nor control
hydrogels. The visible inhibition zone is a result of AMPs being
released from the hydrogels, thus killing bacteria also further
away from the surface, whereas a lack of inhibition zone
implies that the covalently bonded AMPs did not leach out
from the hydrogels. These observations correlated well with
the results from the microscopy images of fluorescent-tagged
AMPs (5(6) carboxyfluorescein-AMP) covalently bonded and
physically adsorbed onto hydrogels and washed for 3 weeks
(Figure S1, Supporting Information). It was shown that AMPs
that were covalently bonded onto hydrogels did not leak out
upon washing with milli-Q water for up to 3 weeks.
PBS Washing. To assess the long-term stability of covalently
bonded AMPs using EDC/NHS chemistry compared to when
they are only physically absorbed onto hydrogel surfaces, a
PBS washing test was performed for a duration of 2 weeks. The
results showed that the covalently bonded AMPs could retain
their antibacterial activity against S.epidermidis for 2 weeks as
shown in Figure 10a, while the physically absorbed AMPs lost
their activity already after 1 day (Figure 10b). These results
clearly show that covalent immobilization of AMPs is vital for
creating AMP-modified hydrogels that preserve their activity
for a long term without leaching AMPs onto the surroundings.
Pilot In Vivo Tests in a Rat Model. A pilot study was
performed to assess the antibacterial activity and performance
of the AMP-hydrogels in vivo using a rat model previously
used for the evaluation of biomaterial-associated infection and
Figure 7. Quantitative analysis of the live and dead fractions of
antimicrobial resistant bacteria. (a) Methicillin-resistant S. aureus, and
(b) multidrug-resistant E. coli on hydrogel surfaces with and without
AMP attachment. Values are mean ± SD, triplicate samples were
used, and three independent experiments were performed (n = 3), *p
< 0.05 compared to control groups (hydrogels with no AMP).
Figure 8. Proportion of dead cells from S. aureus after 24 h on
hydrogel surfaces with and without AMP and previously incubated in
20% human serum for up to 2 days. Data is calculated from the
images of live/dead stained bacteria at each time point. Values are
mean ± SD, duplicate samples were used, and two independent
experiments were performed (n = 2), *p < 0.05 compared to control
groups (hydrogels without AMP) at each time point.
Figure 9. Images of the zone of inhibition of S. aureus (CCUG
56489) around three different types of hydrogels: from left to right is
the control hydrogel, physically adsorbed AMP-hydrogel, and
covalently bonded AMP hydrogels.
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inflammation around titanium surfaces.46 Two dosages of
bacterial inoculation (104 and 2 × 106 CFU) were used, and
the number of viable CFU counts was obtained from retrieved
implants and exudates at two different time points (24 and 72
h). The CFU results are presented in Figure 11 and indicated
10−100× less viable counts of S. aureus on AMP-hydrogels
compared with control hydrogels at both time points and with
both inoculums (Figure 11a and 11b). Although the difference
between the two hydrogels decreased over time, there was still
approximately 10× less bacteria on AMP-hydrogel disks than
on control disks after 72 h. Over time, there was a clear
increase in CFU on the AMP-hydrogels, indicating reduced
antibacterial efficiency. Such behavior can be explained with
our results on AMP stability in serum, which showed that the
AMPs have lost approximately 50% of their antibacterial
functionality after 48 h in human blood serum. Hence, it is
likely that the AMPs lost even more of their activity after 72 h
in the in vivo environment. The number of viable bacteria in
the surrounding exudate was more stable over time, and the
results did not follow a regular pattern. This is likely a result of
a very local antibacterial effect around the hydrogels due to the
covalent bonding of the AMP to the hydrogel surface.
Importantly, the control rats without inoculated bacteria did
not show any S. aureus growth.
Overall, the results from the retrieved hydrogels in the in
vivo pilot study showed a decrease in the number of S. aureus
adhered to AMP-hydrogels compared to control hydrogels.
However, an additional study using an infected wound model
is needed to confirm if the AMP-hydrogels can keep their
activity.
Blood Coagulation Test. One key requirement for proper
wound management is to control bleeding. Blood coagulation
involves the formation of a fibrin clot in the presence of the
wound, which can trap the platelets and release inflammatory
chemokines. Blood coagulation initiates lateral responses to
activate inflammatory responses and subsequent wound
healing.47,48 Therefore, it was investigated how the presence
of AMPs on the hydrogels affect blood coagulation. Here, a
whole blood test using fresh blood from two donors was
performed, and the number of platelets before and after 1 h of
exposure to blood was quantified. A large visible clot was
observed on AMP-hydrogels, whereas no clot formation was
observed on the control, as shown in Figure 12b. In line with
the visual inspection results, platelet counts/counts of free
platelets in the blood (shown in Figure 12a) were significantly
Figure 10. Fluorescence images of dead bacterial cells attached onto
hydrogels incubated in PBS up to 2 weeks. (a) Covalently bonded
AMPs using EDC/NHS coupling. (b) Physically absorbed AMPs.
Dead bacteria were stained by propidium iodide. d = days and W =
weeks.
Figure 11. Colony-forming units of S. aureus (ATCC 25923) associated with hydrogel implants and present in exudates surrounding the hydrogel
at 24 and 72 h after inoculation with (a) 104 and (b) 2 × 106 CFU of S. aureus. Test = AMP-hydrogel; Control = hydrogel without AMPs. Note:
Control hydrogel at 24 h with both infectious doses: arrow represents a “noncountable CFU” due to overgrowth of S. aureus. CFU/mL for these
samples is estimated to be higher than the corresponding Test hydrogel at 24 h).
Figure 12. (a) Number of platelets after whole blood incubation at 37
°C for 60 min. Data represents mean ± SD of four replicate samples,
*p < 0.05 compared to control groups. (b) Photograph showing the
appearance of the hydrogels after 1 h of blood contact.
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lower in the presence of AMPs. The capacity of blood to clot
upon contact with AMP-hydrogels can be explained by the
interaction of positively charged AMPs with blood cells,
platelets, and plasma fibronectin to induce hemostasis.
Furthermore, the capability of hydrogels to absorb blood
facilitated the interaction of blood cells with AMPs to induce
blood clotting.49,50 The results suggest that using AMP-
hydrogel as a wound patch can accelerate blood coagulation
and clot formation for a bleeding wound. That can be
considered as a desirable additional property provided by
AMP-hydrogels apart from the antibacterial effect.
MTT Assays. The viability of primary fibroblasts exposed to
hydrogel-conditioned media, with or without AMP-modifica-
tion, was studied by MTT assays. The results are shown in
Figure 13, where the dotted red line indicates 70% cell
viability, which according to the international standard ISO
10993-5:2009 implies a nontoxic material. A value of 100% is
attributed to cell growth for negative controls (no exposure to
hydrogels). As observed, none of the hydrogel-exposed media
was toxic to human fibroblast cells according to MTT assays.
The results suggest that while the presence of AMPs onto a
hydrogel introduces a strong bactericidal effect, there were no
leachable substances from the AMP-hydrogel that can induce
toxicity to the human-derived cells used in this study. Such a
property makes AMP-hydrogels a suitable antibacterial surface
to be used for the prevention of bacterial infection in wound
management without harming healthy tissue cells behavior.
AMP-Hydrogels in Wound Care Applications. The
AMP-hydrogel designed and evaluated in this study offers
suitable properties of being an ideal wound dressing for the
prevention of infection and acceleration of wound healing.
F127 hydrogels have high water content in their structure,
which facilitates a moist environment, which is often a primary
requirement for a wound dressing material. Moreover, their
high absorptive properties imply that they can absorb large
amounts of liquids, a property that is crucial for moisture
exchange activities between the wound bed and the material to
promote healing.51 It is also known that a high moisture
content and softness of the hydrogels can have a soothing
effect, reduce pain, and increase comfort in the wound area as
compared to viscous fibers and cotton.52 Hydrogels in general
are nonadhesive, and some can even be similar to living tissues
in terms of their biocompatibility properties.53,54 In addition,
hydrogels are nontoxic and easily processable into different
shapes to fit different types of wounds.
Infected wounds delay the healing process. As shown here,
AMP-hydrogels have an ability to kill a broad range of bacterial
species including antibiotic-resistant strains, representing a
preventive wound dressing that can decrease microbial
bioburden and risk of infection in the wound.
Further, the AMP-hydrogel was shown to accelerate blood
clot formation in contact with blood, which is yet another
important criterium for wound dressing materials. As blood
interacts with the AMP-hydrogel, it activates platelets and
forms a fibrin plug to prevent excessive blood loss and to evoke
an inflammatory response, which is beneficial for wound
healing to take place.
To further assess the antibacterial performance of AMP-
hydrogels, additional investigations including a negative AMP
scramble sequence and the use of plasma (which contains
fibrinogen as a key clotting protein) in the in vitro experiments
on stability as well as an in vivo wound healing model are
required.
■ CONCLUSION
Here, we developed an amphiphilic antibacterial hydrogel with
the potential to prevent skin wound infections by covalently
binding a positively charged AMP, RRP9W4N, to an ordered
mesoporous hydrogel consisting of a cross-linked lyotropic
liquid crystal. The material showed a broad spectrum of
antibacterial activity against Gram-positive, Gram-negative,
and antibiotic-resistant bacteria and did not release any toxic
leachable substances to human fibroblast cells. The stability of
AMPs in human serum increased due to the covalent bonding
to the hydrogel and more than 50% of its antibacterial activity
was retained for up to 48 h. The AMP-hydrogel developed in
this work introduces a new contact-killing material for
decreasing the bacterial bioburden in open wounds. This
approach introduces new promise for AMPs to be used in
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